Stay informed with the latest updates for the inheritable blood disorders community. Industry Sangamo Receives FDA Approval for Hemophilia A Gene Therapy TrialJan 10, 2017 Industry BioMarin’s Hemophilia A Gene Therapy Trial Demonstrates Increased FVIII…Jan 9, 2017 Industry Updated: Genentech's Subcutaneous Therapy Performing Well in StudyJan 3, 2017 Industry Octapharma Reports Data on Inhibitor Rates in Nuwiq® Trial Dec 22, 2016 Industry UniQure’s Hemophilia B Gene Therapy Performs Well in Clinical TrialDec 19, 2016 Industry CSL Behring Presents Data on Therapeutic Potential of Idelvion® Dec 15, 2016 Industry Biogen Reports ELOCTATE™ Shows Positive Implications for Quality of LifeDec 14, 2016 Industry Alnylam Reports Progress on Investigational Subcutaneous Hemophilia…Dec 13, 2016 Industry Spark Reports Positive Data from Hemophilia B Gene Therapy ProgramDec 7, 2016 Industry Sangamo Reports Hemophilia A Gene Therapy Progress at ASHDec 7, 2016 Industry Octapharma Announces Two New Clinical TrialsNov 28, 2016 Industry Sangamo’s SB-FIX Receives FDA's Orphan Drug StatusSep 8, 2016 Industry Bayer Announces 2016 BHAP RecipientsAug 31, 2016 Industry Novo Presents Initial Results of B-HERO-S StudyAug 3, 2016 Industry Spark Announces New Data on Its FIX Gene TherapyJun 16, 2016 Pagination First page Previous page … Page 9 Page 10 Page 11 Page 12 Current page 13 Page 14 Page 15 Page 16 Page 17 … Next page Last page